RTS,S/AS01 malaria vaccine mismatch observed among Plasmodium falciparum isolates from southern and central Africa and globally

Scientific Reports

Volumn 8, Issue 1, 2018, Pages

  Pringle, Julia C ^a   Carpi, Giovanna ^a   Almagro Garcia, Jacob ^b,c,d   Zhu, Sha Joe ^b   Kobayashi, Tamaki ^a   Mulenga, Modest ^e   Bobanga, Thierry ^f   Chaponda, Mike ^e   Moss, William J ^a   Norris, Douglas E ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^e TROPICAL DISEASES RESEARCH CENTRE   (Zambia)

^f UNIVERSITY OF KINSHASA   (Congo)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; MALARIA VACCINE; PARASITE ANTIGEN; PROTOZOAL PROTEIN;

ALLELE; AMINO ACID SUBSTITUTION; ANTIGENIC VARIATION; DEMOCRATIC REPUBLIC CONGO; GENE FREQUENCY; GENETIC VARIATION; GENETICS; HAPLOTYPE; HUMAN; IMMUNOLOGY; MALARIA FALCIPARUM; PARASITOLOGY; PLASMODIUM FALCIPARUM; ZAMBIA;

ALLELES; AMINO ACID SUBSTITUTION; ANTIGENIC VARIATION; ANTIGENS, PROTOZOAN; DEMOCRATIC REPUBLIC OF THE CONGO; EPITOPES; GENE FREQUENCY; GENETIC VARIATION; HAPLOTYPES; HUMANS; MALARIA VACCINES; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM; PROTOZOAN PROTEINS; ZAMBIA;

EID: 85045962398     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-018-24585-8     Document Type: Article

References (36)

1. World Health Organization. World Malaria Report (2017).
2. Bhatt, S. et al. The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015. Nature. 526, 207-211 (2015).
3. Mukonka, V. M. et al. High burden of malaria following scale-up of control interventions in Nchelenge District, Luapula Province, Zambia. Malar J. 13, 153 (2014).
4. Clyde, D. F., Most, H., McCarthy, V. C. & Vanderberg, J. P. Immunization of man against sporozite-induced falciparum malaria. Am J Med Sci. 266, 169-177 (1973).
5. Malik, A., Egant, J. E., Houghtent, R. A., Sadofft, J. C. & Hoffman, S. L. Human cytotoxic T lymphocytes against the Plasmodium falciparum circumsporozoite protein. Med Sci. 88, 3300-3304 (1991).
6. Good, M. F. et al. Human T-cell recognition of the circumsporozoite protein of Plasmodium falciparum: Immunodominant T-cell domains map to the polymorphic regions of the molecule. Immunology. 85, 1199-1203 (1988).
7. Zavala, F., Cochrane, A. H., Nardin, E. H., Nussenzweig, R. S. & Nussenzweig, V. Circumsporozoite proteins of malaria parasites contain a single immunodominant region with two or more identical epitopes. J Exp Med. 157, 1947-1957 (1983).
8. Casares, S., Brumeanu, T.-D. & Richie, T. L. The RTS, S malaria vaccine. Vaccine. 28, 4880-4894 (2010).
9. Gordon, D. M. et al. Safety, immunogenicity, and efficacy of a recombinantly produced Plasmodium falciparum circumsporozoite protein-hepatitis B surface antigen subunit vaccine. J Infect Dis. 171, 1576-1585 (1995).
10. Walliker, D. et al. Genetic Analysis of the Human MalariaParasite Plasmodium falciparum. Source Sci New Ser. 236, 1661-1666 (1987).
11. Clinical Trials Partnership. Efficacy and safety of RTS, S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial. Lancet. 386, 31-45 (2015).
12. World Health Organization. Q&A on the malaria vaccine implementation programme (MVIP). http://www. who. int/malaria/media/ malaria-vaccine-implementation-qa/en/ (2018).
13. Jalloh, A., Jalloh, M. & Matsuoka, H. T-cell epitope polymorphisms of the Plasmodium falciparum circumsporozoite protein among field isolates from Sierra Leone: Age-dependent haplotype distribution Malar J. 8, 120 (2009).
14. Zeeshan, M. et al. Genetic Variation in the Plasmodium falciparum Circumsporozoite Protein in India and Its Relevance to RTS, S Malaria Vaccine. Gruner, A. C., ed. PLoS One. 7, e43430 (2012).
15. Barry, A. E., Schultz, L., Buckee, C. O., Reeder, J. C. Contrasting Population Structures of the Genes Encoding Ten Leading Vaccine-Candidate Antigens of the Human Malaria Parasite, Plasmodium falciparum. Rénia, L., ed. PLoS One. 4, e8497 (2009).
16. Waitumbi, J. N. et al. Impact of RTS, S/AS02A and RTS, S/AS01B on genotypes of P. falciparum in adults participating in a malaria vaccine clinical trial. PLoS One. 4, 1-8 (2009).
17. Alloueche, A. et al. Protective Efficacy of the RTS, S/AS02 Plasmodium falciparum Malaria Vaccine is not Strain Specific. Am J Trop Med Hyg. 68, 97-101 (2003).
18. Enosse, S. et al. RTS, S/AS02A malaria vaccine does not induce parasite CSP T cell epitope selection and reduces multiplicity of infection. PLoS Clin Trials. 1, e5 (2006).
19. Bojang, K. A. et al. Efficacy of RTS, S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: A randomised trial. Lancet. 358, 1927-1934 (2001).
20. Neafsey, D. E. et al. Genetic Diversity and Protective Efficacy of the RTS, S/AS01 Malaria Vaccine. N Engl J Med. 373, 2025-2037 (2015).
21. Moss, W. J. et al. JW. Malaria Epidemiology and Control within the International Centers of Excellence for Malaria Research. Am J Trop Med Hyg. 93, 5-15 (2015).
22. Kamuliwo, M. et al. The changing burden of malaria and association with vector control interventions in Zambia using district-level surveillance data, 2006-2011. Malar J. 12, 437 (2013).
23. Parr, J. B. et al. Estimation of Plasmodium falciparum Transmission Intensity in Lilongwe, Malawi, by Microscopy, Rapid Diagnostic Testing, and Nucleic Acid Detection. Am J Trop Med Hyg. 95, 373-377 (2016).
24. Aurrecoechea, C. et al. PlasmoDB: A functional genomic database for malaria parasites. Nucleic Acids Res. 37, D539-D543 (2009).
25. Illumina. 16S Metagenomic Sequencing Library Preparation. Illumina. com. 1-28 (2013).
26. Mag, T. & Salzberg, S. L. FLASH: fast length adjustment of short reads to improve genome assemblies. Bioinformatics. 27, 2957-2963 (2011).
27. Hathaway NJ, Parobek CM, Juliano JJ, Bailey JA. SeekDeep: single-base resolution de novo clustering for amplicon deep sequencing. Nucleic Acids Res. November 2017.
28. The Pf3K Project: pilot data release 5. http://www. malariagen. net/data/pf3k-5 (2016).
29. McKenna, A. et al. The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 20, 1297-1303 (2010).
30. DePristo, M. A. et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat Genet. 43, 491-498 (2011).
31. Zhu, S. J., Almagro-Garcia, J. & McVean, G. Deconvolution of multiple infections in Plasmodium falciparum from high throughput sequencing data. Bioinformatics. 34, 9-15 (2017).
32. Leigh, J. W. & Bryant, D. popart: full-feature software for haplotype network construction. In: S. Nakagawa ed. Methods Ecol Evol. 6, (1110-1116 (2015).
33. Clement, M., Posada, D. & Crandall, K. A. TCS: A computer program to estimate gene genealogies. Mol Ecol. 9, 1657-1659 (2000).
34. Templeton, A. R., Crandall, K. A. & Sing, C. F. A cladistic analysis of phenotypic associations with haplotypes inferred from restriction endonuclease mapping and DNA sequence data. III. Cladogram estimation. Genetics. 132, 619-33 (1992).
35. Preston, M. D. et al. A barcode of organellar genome polymorphisms identifies the geographic origin of Plasmodium falciparum strains. Nat Commun. 5, 1-7 (2014).
36. Bailey, J. A. et al. Use of Massively Parallel Pyrosequencing to Evaluate the Diversity of and Selection on Plasmodium falciparum csp T-Cell Epitopes in Lilongwe, Malawi. J Infect Dis. 206, 580-587 (2012).